<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160301026861N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-24</date_registration>
      <primary_sponsor>Sanandaj University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of two methods of primary washing of the area disinfected with  brown betadine with 70% alcohol and normal saline on the incidence and severity of postoperative wound infection</public_title>
      <acronym></acronym>
      <scientific_title>The Comparison of the Incidence and Severity of Wound Infection to 2 Methods of Primary Prep Washing with 70% Alcohol and Normal Saline in Patients Undergoing Orthopedic Surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>190</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69291</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: At the beginning of the study and based on the entry criteria, patients who meet the conditions for entry into the study are entered into the study. Then, considering the importance of random assignment in clinical trial studies to control possible confounders, the samples are randomly assigned to each of the intervention or control groups in the form of a double block, Blinding description: The method of blinding the study is three-blind. Patients undergoing orthopedic surgery as research samples will not know the type of intervention. Before the study, from an ethical point of view, the samples will be informed that one of two types of intervention may be done for them, and written consent will be obtained from them. The first researcher in the intervention and control group performs the necessary interventions. The second researcher measures the incidence and severity of wound infection after surgery without knowing the type of intervention and the groups; Therefore, as a second person, he will be blind to the study. Also, the statistical consultant as a data analyst will be unaware of the groups; therefore, he will be considered as the third person blinded to the study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary prep area of patients candidates for elective orthopedic surgery of the upper limbs.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The surgical site must be completely shaved. The surgical area will be prepped with 5.7% betadine brown diluted with normal saline for three minutes. After the initial prep, betadine will be brown on the skin surface for two minutes. Then the surgical site is washed with 70% alcohol until the skin surface is free of betadine. Wait until the alcohol dries on the surface of the skin. After the intervention, secondary prep will be done with betadine 10% and with the help of three gauzes and for at least five minutes. Intervention 2: Control group: the surgical site must be completely shaved. The surgical area will be prepped with 7.5%brown betadine diluted with normal saline for three minutes. After the initial prep, brown will be  on the skin surface for two minutes. Then, the surgical site is washed with normal saline until the skin surface is free of betadine. Then, using a sterile towel, the primary prep area will be dried. . After washing or normal saline serum and drying, secondary prep of the surgical area will be done again with betadine 10% and with the help of three gauzes and for at least five minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Results of data analysis

When:
6 months after the results are published

To whom:
Researchers working in academic and scientific institutions

Conditions:
For use in meta-analysis, systematic review and compilation of clinical guidelines

Where to obtain:
Jamal Seidi
 Bs,  MSc,  PhD .Nursing 
Associate Professor of Nursing and Midwifery Faculty. Kurdistan University of medical sciences, Sanandaj, Iran 
Email : jamal.seidi@yahoo.com 
Jamal.seidi@muk.ac.ir
mobile:+98-918-378-1006

How to obtain:
Written and valid request by e-mail jamal.seidi@yahoo.com

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Jamal Seidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pasdaran Blvd; Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran</address>
        <city>Sanandaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6617713446</zip>
        <telephone>+98 87 3366 0095</telephone>
        <email>jamal.seidi@muk.ac.ir</email>
        <affiliation>Sanandaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Jamal Seidi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Pasdaran Blvd; Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran</address>
        <city>Sanandaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6617713446</zip>
        <telephone>+98 87 3366 0095</telephone>
        <email>jamal.seidi@muk.ac.ir</email>
        <affiliation>Sanandaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient is a volunteer for elective orthopedic surgery of the upper limb
The patient is a volunteer to participate in the research
The hair in the surgical area must be shaved before the operation
The body mass index of the patient is less than 30</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>There should be no skin damage in the surgical area due to trauma
The patient does not have any underlying diseases or skin allergies
The patient does not have burns or previous surgery in the prep area
The patient does not have vascular problems in the organ under surgery
The patient does not have diseases related to the immune system and infectious diseases
The patient does not have digestive or blood diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The surgical site must be completely shaved. The surgical area will be prepped with 5.7% betadine brown diluted with normal saline for three minutes. After the initial prep, betadine will be brown on the skin surface for two minutes. Then the surgical site is washed with 70% alcohol until the skin surface is free of betadine. Wait until the alcohol dries on the surface of the skin. After the intervention, secondary prep will be done with betadine 10% and with the help of three gauzes and for at least five minutes.</i_keyword>
      <i_keyword>Control group: the surgical site must be completely shaved. The surgical area will be prepped with 7.5%brown betadine diluted with normal saline for three minutes. After the initial prep, brown will be  on the skin surface for two minutes. Then, the surgical site is washed with normal saline until the skin surface is free of betadine. Then, using a sterile towel, the primary prep area will be dried. . After washing or normal saline serum and drying, secondary prep of the surgical area will be done again with betadine 10% and with the help of three gauzes and for at least five minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The incidence of wound infection after surgery with a score higher than ten from the wound evaluation and the absence of wound infection with a score lower than 10 will be measured by the ASEPSIS INDEX tool after orthopedic surgery. Timepoint: It will be measured once. The symptoms of wound infection will be monitored from the time after surgery until two weeks after discharge from the hospital, and on the 14th day after discharge, the scores obtained from the Asepsis index tool will be collected. Method of measurement: Based on the ASEPSIS INDEX tool, evaluation of wound healing after surgery including; Complementary antibiotic therapy (0-10 points), redness of the wound at the surgical site (0-5 points), serous discharge from the surgical site (0-5 points), deep disintegration of the wound (0-10 points), culture from the wound site and isolation of bacteria ( 0-10 points) Wound debridement under general anesthesia (0-10 points), drainage of purulent wound secretions under local anesthesia, purulent exudate (0-10 points), hospitalization for more than 14 days (0-5 points). The maximum score will be 70 and the minimum score will be zero. A score less than ten means complete healing of the wound and no wound infection. A score higher than ten means wound infection.</prim_outcome>
      <prim_outcome>The severity of wound infection after surgery will be determined based on the ASEPSIS INDEX standard tool. Based on this tool, a score of 0-10 indicates complete healing of the wound, a score of 11-20 indicates impaired wound healing, a score of 21-30 indicates partial wound infection, a score of 31-40 indicates moderate wound infection, and a score greater than 40 indicates severe wound infection. Timepoint: It will be measured once. The symptoms of wound infection will be monitored from the time after surgery until two weeks after discharge from the hospital, and on the 14th day after discharge, the scores obtained from the Asepsis index tool will be collected. Method of measurement: In this study, the average scores obtained from the ASEPSIS INDEX standard tool will be compared in two intervention and control groups.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sanandaj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-24</approval_date>
        <contact_name>Ethics Committee of Kurdistan University of Medical Sciences</contact_name>
        <contact_address>Pasdaran Blvd; Faculty of Nursing and Midwifery; Kurdistan University of Medical Sciences, Sanandaj, Iran Sanandaj Kurdistan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
